The patient’s HHT symptoms are most likely due to her ENG pathogenic variant, but given her father and half-brother’s clinically significant epistaxis, a synergistic contribution of her GDF2 VUS to her symptoms cannot be excluded completely. This evidence concerns the gene GDF2 and epistaxis.